3D-Printed Ginsenoside Rb1-Loaded Mesoporous Calcium Silicate/Calcium Sulfate Scaffolds for Inflammation Inhibition and Bone Regeneration.
3D printing
calcium sulfate
ginsenoside Rb1
inflammation
mesoporous calcium silicate
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
28 Jul 2021
28 Jul 2021
Historique:
received:
14
06
2021
revised:
23
07
2021
accepted:
25
07
2021
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
28
8
2021
Statut:
epublish
Résumé
Bone defects are commonly found in the elderly and athletic population due to systemic diseases such as osteoporosis and trauma. Bone scaffolds have since been developed to enhance bone regeneration by acting as a biological extracellular scaffold for cells. The main advantage of a bone scaffold lies in its ability to provide various degrees of structural support and growth factors for cellular activities. Therefore, we designed a 3D porous scaffold that can not only provide sufficient mechanical properties but also carry drugs and promote cell viability. Ginsenoside Rb1 (GR) is an extract from panax ginseng, which has been used for bone regeneration and repair since ancient Chinese history. In this study, we fabricated scaffolds using various concentrations of GR with mesoporous calcium silicate/calcium sulfate (MSCS) and investigated the scaffold's physical and chemical characteristic properties. PrestoBlue, F-actin staining, and ELISA were used to demonstrate the effect of the GR-contained MSCS scaffold on cell proliferation, morphology, and expression of the specific osteogenic-related protein of human dental pulp stem cells (hDPSCs). According to our data, hDPSCs cultivated in GR-contained MSCS scaffold had preferable abilities of proliferation and higher expression of the osteogenic-related protein and could effectively inhibit inflammation. Finally, in vivo performance was assessed using histological results that revealed the GR-contained MSCS scaffolds were able to further achieve more effective hard tissue regeneration than has been the case in the past. Taken together, this study demonstrated that a GR-containing MSCS 3D scaffold could be used as a potential alternative for future bone tissue engineering studies and has good potential for clinical use.
Identifiants
pubmed: 34440111
pii: biomedicines9080907
doi: 10.3390/biomedicines9080907
pmc: PMC8389633
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Int Endod J. 2002 Oct;35(10):807-11
pubmed: 12406373
Mater Sci Eng C Mater Biol Appl. 2021 Feb;119:111621
pubmed: 33321663
Acta Biomater. 2011 Jun;7(6):2604-14
pubmed: 21345382
Int Immunopharmacol. 2020 Oct;87:106805
pubmed: 32731179
Adv Healthc Mater. 2019 Apr;8(8):e1801298
pubmed: 30773833
Mater Sci Eng C Mater Biol Appl. 2021 Mar;122:111928
pubmed: 33641921
Chin Med. 2020 May 6;15:42
pubmed: 32391072
Acta Biomater. 2021 Jun;127:338-352
pubmed: 33831571
Biomedicines. 2021 Feb 17;9(2):
pubmed: 33671187
J Endod. 2018 Nov;44(11):1677-1685
pubmed: 30409449
Mater Sci Eng C Mater Biol Appl. 2015 Nov 1;56:165-73
pubmed: 26249577
Mater Sci Eng C Mater Biol Appl. 2021 Feb;119:111631
pubmed: 33321670
Biomedicines. 2021 Apr 16;9(4):
pubmed: 33923505
J Endod. 2019 Nov;45(11):1349-1356
pubmed: 31543273
Sci Rep. 2016 May 04;6:25282
pubmed: 27141994
Macromol Biosci. 2020 Dec;20(12):e2000256
pubmed: 33164317
Mater Sci Eng C Mater Biol Appl. 2019 Nov;104:109855
pubmed: 31500067
Pharmaceutics. 2018 Jul 18;10(3):
pubmed: 30021937
J Mater Sci Mater Med. 2017 Dec 27;29(1):11
pubmed: 29282550
Mater Sci Eng C Mater Biol Appl. 2021 Jun;125:112092
pubmed: 33965102
Front Pharmacol. 2020 Jan 23;10:1565
pubmed: 32038244
Mater Sci Eng C Mater Biol Appl. 2020 Nov;116:111148
pubmed: 32806300
Mater Sci Eng C Mater Biol Appl. 2021 Feb;121:111741
pubmed: 33579436
Mater Sci Eng C Mater Biol Appl. 2019 May;98:1145-1158
pubmed: 30812998
Mater Sci Eng C Mater Biol Appl. 2019 Nov;104:109887
pubmed: 31500024
J Mater Sci Mater Med. 2015 Dec;26(12):276
pubmed: 26543022
Mater Sci Eng C Mater Biol Appl. 2019 May;98:949-959
pubmed: 30813102
Polymers (Basel). 2019 Dec 11;11(12):
pubmed: 31835840
Mater Sci Eng C Mater Biol Appl. 2021 Feb;119:111629
pubmed: 33321669
Biomedicines. 2021 Jan 29;9(2):
pubmed: 33572786
ACS Biomater Sci Eng. 2020 Dec 14;6(12):6737-6747
pubmed: 33320641
Mater Sci Eng C Mater Biol Appl. 2017 Apr 1;73:726-735
pubmed: 28183667
Polymers (Basel). 2020 Jun 29;12(7):
pubmed: 32610580
J Ginseng Res. 2020 Nov;44(6):823-832
pubmed: 33192126
Mater Sci Eng C Mater Biol Appl. 2020 Jun;111:110757
pubmed: 32279738
Mater Sci Eng C Mater Biol Appl. 2020 May;110:110691
pubmed: 32204116
Acta Biomater. 2008 May;4(3):646-55
pubmed: 18083642
Biomedicines. 2021 Jun 23;9(7):
pubmed: 34201589
Sci Adv. 2020 Mar 20;6(12):eaaz6725
pubmed: 32219170